305 related articles for article (PubMed ID: 23330660)
21. Importance of molecular computer modeling in anticancer drug development.
Geromichalos GD
J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
[TBL] [Abstract][Full Text] [Related]
22. The impact of assay technology as applied to safety assessment in reducing compound attrition in drug discovery.
Thomas CE; Will Y
Expert Opin Drug Discov; 2012 Feb; 7(2):109-22. PubMed ID: 22468913
[TBL] [Abstract][Full Text] [Related]
23. Non-stoichiometric inhibition in integrated lead finding - a literature review.
Klumpp M
Expert Opin Drug Discov; 2016; 11(2):149-62. PubMed ID: 26653534
[TBL] [Abstract][Full Text] [Related]
24. How to Prepare a Compound Collection Prior to Virtual Screening.
Bologa CG; Ursu O; Oprea TI
Methods Mol Biol; 2019; 1939():119-138. PubMed ID: 30848459
[TBL] [Abstract][Full Text] [Related]
25. Role of computer-aided drug design in modern drug discovery.
Macalino SJ; Gosu V; Hong S; Choi S
Arch Pharm Res; 2015 Sep; 38(9):1686-701. PubMed ID: 26208641
[TBL] [Abstract][Full Text] [Related]
26. Advancing fragment binders to lead-like compounds using ligand and protein-based NMR spectroscopy.
Maurer T
Methods Enzymol; 2011; 493():469-85. PubMed ID: 21371602
[TBL] [Abstract][Full Text] [Related]
27. Virtual screening of compound libraries.
Cerqueira NM; Sousa SF; Fernandes PA; Ramos MJ
Methods Mol Biol; 2009; 572():57-70. PubMed ID: 20694685
[TBL] [Abstract][Full Text] [Related]
28. Virtual screening for lead discovery.
Tang YT; Marshall GR
Methods Mol Biol; 2011; 716():1-22. PubMed ID: 21318897
[TBL] [Abstract][Full Text] [Related]
29. The role of computational methods in the identification of bioactive compounds.
Glick M; Jacoby E
Curr Opin Chem Biol; 2011 Aug; 15(4):540-6. PubMed ID: 21411361
[TBL] [Abstract][Full Text] [Related]
30. The importance of employing computational resources for the automation of drug discovery.
Rosales-Hernández MC; Correa-Basurto J
Expert Opin Drug Discov; 2015 Mar; 10(3):213-9. PubMed ID: 25682781
[TBL] [Abstract][Full Text] [Related]
31. Using computational techniques in fragment-based drug discovery.
Desjarlais RL
Methods Enzymol; 2011; 493():137-55. PubMed ID: 21371590
[TBL] [Abstract][Full Text] [Related]
32. High-throughput screening and structure-based approaches to hit discovery: is there a clear winner?
Jhoti H; Rees S; Solari R
Expert Opin Drug Discov; 2013 Dec; 8(12):1449-53. PubMed ID: 24206191
[TBL] [Abstract][Full Text] [Related]
33. Small-world phenomena in chemical library networks: application to fragment-based drug discovery.
Tanaka N; Ohno K; Niimi T; Moritomo A; Mori K; Orita M
J Chem Inf Model; 2009 Dec; 49(12):2677-86. PubMed ID: 19961207
[TBL] [Abstract][Full Text] [Related]
34. Novel inhibitor discovery through virtual screening against multiple protein conformations generated via ligand-directed modeling: a maternal embryonic leucine zipper kinase example.
Mahasenan KV; Li C
J Chem Inf Model; 2012 May; 52(5):1345-55. PubMed ID: 22540736
[TBL] [Abstract][Full Text] [Related]
35. Optimization methods for virtual screening on novel computational architectures.
Pérez-Sánchez H; Wenzel W
Curr Comput Aided Drug Des; 2011 Mar; 7(1):44-52. PubMed ID: 20883205
[TBL] [Abstract][Full Text] [Related]
36. Retrieving novel C5aR antagonists using a hybrid ligand-based virtual screening protocol based on SVM classification and pharmacophore models.
Qing XY; Zhang CH; Li LL; Ji P; Ma S; Wan HL; Wang ZR; Zou J; Yang SY
J Biomol Struct Dyn; 2013; 31(2):215-23. PubMed ID: 22831459
[TBL] [Abstract][Full Text] [Related]
37. Enhancements of screening collections to address areas of unmet medical need: an industry perspective.
Drewry DH; Macarron R
Curr Opin Chem Biol; 2010 Jun; 14(3):289-98. PubMed ID: 20413343
[TBL] [Abstract][Full Text] [Related]
38. Quantum probability ranking principle for ligand-based virtual screening.
Al-Dabbagh MM; Salim N; Himmat M; Ahmed A; Saeed F
J Comput Aided Mol Des; 2017 Apr; 31(4):365-378. PubMed ID: 28220440
[TBL] [Abstract][Full Text] [Related]
39. Assessment of chemical libraries for their druggability.
Sirois S; Hatzakis G; Wei D; Du Q; Chou KC
Comput Biol Chem; 2005 Feb; 29(1):55-67. PubMed ID: 15680586
[TBL] [Abstract][Full Text] [Related]
40. Receptor-based virtual screening protocol for drug discovery.
Cerqueira NM; Gesto D; Oliveira EF; Santos-Martins D; Brás NF; Sousa SF; Fernandes PA; Ramos MJ
Arch Biochem Biophys; 2015 Sep; 582():56-67. PubMed ID: 26045247
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
